You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly diagnosed FLT3-mutation negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • (no location specified)
Oct 18, 2022

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +132 more
Jan 24, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Decitabine and Cedazuridine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 19, 2022

Acute Myeloid Leukemia Trial in Worldwide (Midostaurin, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Hong Kong, Hong Kong
  • +40 more
Jan 20, 2023

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

Unknown status
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 9, 2020

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Los Angeles, California
  • +110 more
Jan 26, 2023

Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia Trial in Japan, Korea, Republic of, Taiwan (gilteritinib,

Active, not recruiting
  • Acute Myeloid Leukemia
  • FLT3-mutated Acute Myeloid Leukemia
  • Anjo, Aichi, Japan
  • +54 more
Jan 10, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Subjects Treated With CARv3-TEAM-E T Cells

Not yet recruiting
  • Glioblastoma Recurrent, EGFR vIII Mutant
  • +2 more
  • Disease assessments
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 23, 2021

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Acute Myeloid Leukemia Trial in Spain (Quizartinib, Placebo oral tablet, Cytarabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Santiago De Compostela, A Coruña, Spain
  • +44 more
Jan 20, 2022

Acute Myeloid Leukemia Trial in Worldwide (Midostaurin)

Completed
  • Acute Myeloid Leukemia
  • Pleven, Bulgaria
  • +85 more
Feb 11, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 16, 2022

AML, FLT3-ITD Mutation Trial in Hong Kong (Sorafenib, Omacetaxine Mepesuccinate Injection)

Completed
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Mar 26, 2020

Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression

Completed
  • Response Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK Expression
  • JAK expression
  • Mansoura, Egypt
    Mansoura University Hospital
Dec 9, 2020

Newly Diagnosed AML With FLT3 Activating Mutations Trial in United States (crenolanib, cytarabine, daunorubicin)

Completed
  • Newly Diagnosed AML With FLT3 Activating Mutations
  • Duarte, California
  • +8 more
Jul 17, 2020

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Lymphoblastic Leukemia Trial in United States (Calaspargase pegol (S95015))

Recruiting
  • Acute Lymphoblastic Leukemia
  • Calaspargase pegol (S95015)
  • Scottsdale, Arizona
  • +14 more
Dec 13, 2022

Acute Myeloid Leukemia Trial in Germany (MODULE: conventional chemo (Cytarabine+Daunorubicin) in combination with

Active, not recruiting
  • Acute Myeloid Leukemia
  • MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO
  • +4 more
  • München, Bayern, Germany
  • +10 more
Aug 31, 2021

Acute Myeloid Leukemia Trial in Germany (midostaurin (PKC412))

Completed
  • Acute Myeloid Leukemia
  • midostaurin (PKC412)
  • Chemnitz, Germany
  • +9 more
Aug 5, 2020

Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United

Recruiting
  • Embryonal Rhabdomyosarcoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Aug 17, 2022